• 1
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340: 74550.
  • 2
    Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer [letter]. Lancet 1998;351: 2145.
  • 3
    Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350: 11423.
  • 4
    Irvine HDV, Goldberg D, Hole DJ, McMenamin J. Trends in primary liver cancer [letter]. Lancet 1998;351: 2156.
  • 5
    Mant JW, Vessey MP. Trends in mortality from primary liver cancer in England and Wales 1975–92: influence of oral contraceptives. Br J Cancer 1995;72: 8003.
  • 6
    KakizoeT (ed). Cancer statistics in Japan—1997. Foundation for Promotion of Cancer Research. Tokyo: National Cancer Center, 1997. p 172.
  • 7
    Stuver SO, Trichopoulos D. Liver cancer. Cancer Surv 1994;19/20: 99124.
  • 8
    Ron E, Carter R, Jablon S, Mabuchi K. Agreement between death certificate and autopsy diagnoses among atomic bomb survivors. Epidemiology 1994;5: 4856.
  • 9
    Percy C, Ries LG, Van Holten VD. The accuracy of liver cancer as the underlying cause of death on death certificates. Public Health Rep 1990;105: 3617.
  • 10
    Castaldo G, Oriani G, Lofrano MM, et al. Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes. Clin Chem 1996;42: 12639.
  • 11
    Castaldo G, Calcagno G, Sibillo R, Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis. Clin Chem 2000;46: 9016.
  • 12
    Stroffolini T, Andreone P, Andriulli A, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998;29: 9442.
  • 13
    Shin HR, Lee CU, Park HJ, Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996;25: 93340.
  • 14
    ParkinDM, WhelanS, FerlayJ, RarymondL, YoungJ (eds). Cancer incidence in five continents, 143rd ed, volume VII. Lyon, France: IARC Scientific Publications, 1997.
  • 15
    Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47: 496772.
  • 16
    Preston DL, Kato H, Kopecky KJ, Fujita S. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950–1982. Radiat Res 1987; 111: 15178.
  • 17
    Cologne JB, Tokuoka S, Beebe GW, Fukuhara T, Mabuchi K, Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat Res 1999;152: 36473.
  • 18
    Gibson JB, Sobin LH. Histological typing of tumours of the liver, biliary tract and pancreas. International histological classification of tumours, 20th ed. Geneva: World Health Organization, 1978.
  • 19
    Frome EL, Checkoway H. Use of poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 1985;121: 30923.
  • 20
    Breslow NE, Day NE. Statistical methods in cancer research. Volume IIThe design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987.
  • 21
    Sposto R, Preston DL. Correcting for catchment area nonresidency in studies based on tumor-registry data. CR1-92, Hiroshima, Japan: Radiation Effects Research Foundation, 1992.
  • 22
    Pierce DA, Preston DL. Joint analysis of site-specific cancer risks for the atomic bomb survivors. Radiat Res 1993;134: 13442.
  • 23
    Harrell FE, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988;80: 1198202.
  • 24
    Lyass O, Brufman G, Edelmann DZ, et al. Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature. Eur J Gynaecol Oncol 1997;18: 6870.
  • 25
    Castaldo G, Oriani G, Cimino L, et al. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase. Clin Chem 1994;40: 47883.
  • 26
    Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999;29: 1596601.
  • 27
    Andersen IB, Sorensen TIA, Prener A. Increase in incidence of disease due to diagnostic drift: primary liver cancer in Denmark, 1943–85. BMJ 1991;302: 43740.
  • 28
    Benhamiche AM, Faivre C, Minello A, et al. Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976–1995. J Hepatol 1998;29: 8026.
  • 29
    Makimoto K, Higuchi S. Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol 1999;28: 304.
  • 30
    Nishioka K, Watanabe J, Furuta S, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67: 42933.